Komori
Qol Holdings (3034) · RiskMaterialised

Goodwill Impairment Associated with M&A

First written in FY2016. 11 of 11 entries say "Materialised", first in FY2016. Latest entry: FY2026.

11entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMaterialisedFY2016 – FY20262016: 120162017: 120172018: 020182019: 120192020: 220202021: 220212022: 120222023: 020232024: 120242025: 020252026: 22026
Same theme, other companies
Impairment of Goodwill and Trademark Rights Associated with AcquisitionsA theme 206 companies write about · 208 as a headwind · 0 as a tailwind

Qol Holdings moved to the "Worse" side of this theme in 2016, 8 years before the typical company in this theme (2024).

The whole theme swung hardest in 2023: 35 of 98 companies on the "Worse" side.

53 other companies' latest entry also says "Materialised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 208 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MaterialisedAnnual report

    「During the fiscal year, the company recorded an impairment loss of ¥393 million on stores and other assets in the Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku and Kyushu regions.」

    The company recorded an impairment loss of ¥393 million on stores and other assets, and the risk of impairment to asset groups, including goodwill, actually materialized during the fiscal year.
  2. 2026-06-02MaterialisedGeneral Meetings of Shareholders

    「During the fiscal year under review, the Group recognized impairment losses on the following asset groups.」

    The company recognized an impairment loss of ¥393 million on stores and other assets. It also reported goodwill of ¥36,423 million, uncertainty in estimates of prescription volumes and the possibility of recognizing further impairment in the future.
  3. FY2024MaterialisedAnnual report

    「During the fiscal year, the company recorded an impairment loss of ¥325 million on stores and other assets in the Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku and Kyushu regions.」

    The company recorded an impairment loss of ¥325 million on stores and other assets, and the risk of impairment to asset groups, including goodwill arising from M&A and other transactions, also materialized during the fiscal year.
  4. FY2022MaterialisedAnnual report

    「During the fiscal year, the company recorded an impairment loss of ¥374 million on stores and other assets in the Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku and Kyushu regions.」

    The company recorded an impairment loss of ¥374 million on stores and other assets, and the risk of impairment to asset groups, including goodwill arising from M&A and other transactions, also materialized during the fiscal year.
  5. FY2021MaterialisedAnnual report

    「During the fiscal year, the company recorded an impairment loss of ¥759 million on stores and other assets in the Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku and Kyushu regions.」

    The company recorded an impairment loss of ¥759 million on stores and other assets, increasing the full-year amount from ¥417 million for the previous cumulative third quarter. In the Kanto and Chugoku regions, the affected asset groups included goodwill.
  6. FY2021-Q3MaterialisedAnnual report

    「The company recorded impairment losses of ¥109 million in the Insurance Pharmacy Business segment and ¥308 million in the Medical-Related Business segment. The total impairment loss recorded for the cumulative third quarter of the fiscal year was ¥417 million.」

    For the cumulative third quarter, the company recorded impairment losses of ¥417 million, comprising ¥109 million in the Insurance Pharmacy Business and ¥308 million in the Medical-Related Business.
  7. FY2021-Q2MaterialisedAnnual report

    「The company recorded impairment losses of ¥88 million in the Insurance Pharmacy Business segment and ¥308 million in the Medical-Related Business segment. The total impairment loss recorded for the cumulative second quarter of the fiscal year was ¥396 million.」

    For the cumulative second quarter, the company recorded impairment losses of ¥88 million in the Insurance Pharmacy Business and ¥308 million in the Medical-Related Business, for a total of ¥396 million.
  8. FY2020MaterialisedAnnual report

    「During the consolidated fiscal year, the Group recorded impairment losses of ¥295 million on stores and other assets in the Kanto, Chubu, Kinki and Kyushu regions.」

    The company recorded an impairment loss of ¥295 million on stores and other assets, and the risk of impairment to asset groups, including goodwill arising from M&A and other transactions, also materialized during the fiscal year.
  9. FY2019MaterialisedAnnual report

    「During the consolidated fiscal year, the Group recorded impairment losses of ¥340 million on stores and other assets in the Kanto, Chubu and Kinki regions.」

    The Group recorded impairment losses of ¥340 million on stores and other assets, indicating that the impairment risk for asset groups including goodwill materialized again during the fiscal year.
  10. FY2017MaterialisedAnnual report

    「During the consolidated fiscal year, the Group recorded impairment losses of ¥152 million on stores and other assets in the Tohoku, Kanto and Kinki regions.」

    The Group recorded impairment losses of ¥152 million during the fiscal year on store assets, including goodwill arising from M&A and other transactions.
  11. FY2016MaterialisedAnnual report

    「If the Group is unable to secure earnings as planned in the future, impairment losses relating to goodwill may arise and affect the Group's business performance and other matters.」

    The Group recorded impairment losses of ¥499 million in the fiscal year, including an asset group containing goodwill, indicating that the risk has materialized.
Moved together

"Revenue and Profit Growth" moved the same way as this thread, in the same document, in 5 of its 11 moves.

5522★1234
  1. ★This thread
  2. 1Revenue and Profit Growth5×
  3. 2Impact of Disasters, Epidemics and Other Events on Store Operations5×
  4. 3Impact of Drug Price Revisions and Dispensing Fee Revisions2×
  5. 4Realizing an Optimal Business Portfolio2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Qol Holdings's next results are scheduled for 2026-11-05. Read the earnings preview It last moved in the General Meetings of Shareholders of 2026-06-02: "Materialised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Goodwill Impairment Associated with M&A | Qol Holdings Co.,Ltd. (3034) | Komori